Skip to main content
. 2022 Jul 23;13(7):644. doi: 10.1038/s41419-022-05075-2

Fig. 1. An overview of major developments in the RNA-targeting field.

Fig. 1

A timeline of RNA-based technological advances, drug approvals and other important events are highlighted. Rapid development in the RNA-targeting field has been applied to treat rare and common diseases. ASOs antisense oligonucleotides, RNAi RNA interference, RISC RNA-induced silencing complex, siRNA small interfering RNA, saRNA small activating RNAs, ssRNA single-stranded RNA.